iPSC Manufacturing Starts with the Source

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 21 Oct, 16:00 UTC

For iPSC developers, scalable manufacturing begins long before the bioreactor. Pluristyx leaders explain why starting material, process discipline, automation, and shared data will help therapies reach patients reliably and affordably. The post iPSC Manufacturing Starts with the Source appeared…